HB788
Log in to followAN ACT relating to buprenorphine products.
Create a new section of KRS Chapter 311 to require that a dosage regimen for Buprenorphine-Mono-Product or Buprenorphine-Combined-with-Naloxone prescribed by a licensed physician to meet the treatment needs of a patient; require the Kentucky Board of Medical Licensure to promulgate administrative regulations to implement the requirement; create a new section of KRS Chapter 314 to require that a dosage regimen for Buprenorphine-Mono-Product or Buprenorphine-Combined-with-Naloxone prescribed by a licensed advanced practice registered nurse meet the treatment needs of a patient; require the Kentucky Board of Nursing to promulgate administrative regulations to implement the requirement.
Introduced: February 19, 2025
Last action: March 5, 2025
Plain-language summary
This bill would require doctors and advanced practice nurses in Kentucky to prescribe buprenorphine — a medication commonly used to treat opioid addiction — in a dosage that meets each individual patient's treatment needs. It directs the Kentucky Board of Medical Licensure and the Kentucky Board of Nursing to create rules carrying out this requirement. Who it may affect: Kentuckians receiving medication-based treatment for opioid use disorder, and the physicians and advanced practice registered nurses who prescribe their care.
Open official bill text (PDF)·Report a problem with the summary
Legislative History
Primary Sponsor
Co-sponsors (1)
Bill Text Versions
Something wrong on this page? Tell us